Phosphorylation of human DNA polymerase λ by the cyclin-dependent kinase Cdk2/cyclin A complex is modulated by its association with proliferating cell nuclear antigen

被引:39
|
作者
Frouin, I [1 ]
Toueille, M [1 ]
Ferrari, E [1 ]
Shevelev, I [1 ]
Hübscher, U [1 ]
机构
[1] Univ Zurich, Inst Vet Biochem & Mol Biol, CH-8057 Zurich, Switzerland
关键词
D O I
10.1093/nar/gki845
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
DNA polymerase (Pol) lambda is a member of the Pol X family and possesses four different enzymatic activities, being DNA polymerase, terminal transferase, deoxyribose phosphate lyase and polynucleotide synthetase, all localized in its C-terminal region. On the basis of its biochemical properties, Pol lambda has been implicated in various DNA repair pathways, such as abasic site translesion DNA synthesis, base excision repair and non-homologous end joining of double strand breaks. However, its role in vivo has not yet been elucidated. In addition, Pol lambda has been shown to interact with the replication clamp proliferating cell nuclear antigen (PCNA) in vitro and in vivo. In this work, we searched by affinity chromatography for novel partners and we identified the cyclin-dependent kinase Cdk2 as novel partner of Pol lambda. Pol lambda is phosphorylated in vitro by several Cdk/cyclin complexes, including Cdk2/cyclin A, in its prolineserine-rich domain. While the polymerase activity of Pol lambda was not affected by Cdk2/cyclin A phosphorylation, phosphorylation of Pol lambda was decreased by its interaction with PCNA. Finally, Pol lambda is also phosphorylated in vivo in human cells and this phosphorylation is modulated during the cell cycle.
引用
收藏
页码:5354 / 5361
页数:8
相关论文
共 50 条
  • [41] Comparison of deregulated expression of cyclin D1 and cyclin E with that of cyclin dependent kinase 4 (CDK4) and CDK2 in human oesophageal squamous cell carcinoma
    Matsumoto, M
    Furihata, M
    Ishikawa, T
    Ohtsuki, Y
    Ogoshi, S
    BRITISH JOURNAL OF CANCER, 1999, 80 (1-2) : 256 - 261
  • [42] Dinaciclib, a cyclin-dependent kinase inhibitor, suppresses cholangiocarcinoma growth by targeting CDK2/5/9
    Saqub, Hera
    Proetsch-Gugerbauer, Hannah
    Bezrookove, Vladimir
    Nosrati, Mehdi
    Vaquero, Edith M.
    de Semir, David
    Ice, Ryan J.
    McAllister, Sean
    Soroceanu, Liliana
    Kashani-Sabet, Mohammed
    Osorio, Robert
    Dar, Altaf A.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [43] Discovery of INCB123667, a potent and selective cyclin-dependent kinase 2 (CDK2) inhibitor for the treatment of cyclin E dysregulated cancers
    Wee, S.
    Ye, M.
    Lo, Y.
    Hansbury, M.
    Shin, N.
    Weber, M.
    Roman, V.
    Huo, L.
    Skaggs, H.
    Drake, K.
    Kapilashrami, K.
    Stump, K.
    Yang, J.
    Chand, S.
    Timmers, C.
    Hummel, J.
    Ye, Y.
    Zhang, G.
    Yang, Y. O.
    Covington, M.
    Wu, L.
    Koblish, H.
    Kim, S.
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : S79 - S79
  • [44] Understanding and modulating cyclin-dependent kinase inhibitor specificity: molecular modeling and biochemical evaluation of pyrazolopyrimidinones as CDK2/cyclin A and CDK4/cyclin D1 inhibitors
    Rossi, KA
    Markwalder, JA
    Seitz, SP
    Chang, CH
    Cox, S
    Boisclair, MD
    Brizuela, L
    Brenner, SL
    Stouten, PFW
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2005, 19 (02) : 111 - 122
  • [45] Dinaciclib, a cyclin-dependent kinase inhibitor, suppresses cholangiocarcinoma growth by targeting CDK2/5/9
    Hera Saqub
    Hannah Proetsch-Gugerbauer
    Vladimir Bezrookove
    Mehdi Nosrati
    Edith M. Vaquero
    David de Semir
    Ryan J. Ice
    Sean McAllister
    Liliana Soroceanu
    Mohammed Kashani-Sabet
    Robert Osorio
    Altaf A. Dar
    Scientific Reports, 10
  • [46] Understanding and modulating cyclin-dependent kinase inhibitor specificity: molecular modeling and biochemical evaluation of pyrazolopyrimidinones as CDK2/cyclin A and CDK4/cyclin D1 inhibitors
    Karen A. Rossi
    Jay A. Markwalder
    Steven P. Seitz
    Chong-Hwan Chang
    Sarah Cox
    Michael D. Boisclair
    Leonardo Brizuela
    Stephen L. Brenner
    Pieter F. W. Stouten
    Journal of Computer-Aided Molecular Design, 2005, 19 : 111 - 122
  • [47] ABNORMAL ALZHEIMER-LIKE PHOSPHORYLATION OF TAU-PROTEIN BY CYCLIN-DEPENDENT KINASES CDK2 AND CDK5
    BAUMANN, K
    MANDELKOW, EM
    BIERNAT, J
    PIWNICAWORMS, H
    MANDELKOW, E
    FEBS LETTERS, 1993, 336 (03): : 417 - 424
  • [48] Association of cyclin A and cdk2 with SV40 DNA in replication initiation complexes is cell cycle dependent
    Dominique Cannella
    James M. Roberts
    Rati Fotedar
    Chromosoma, 1997, 105 (6) : 349 - 359
  • [49] Rapamycin disrupts cyclin/cyclin-dependent kinase/p21/proliferating cell nuclear antigen complexes and cyclin D1 reverses rapamycin action by stabilizing these complexes.
    Law, M
    Forrester, E
    Chytil, A
    Corsino, P
    Green, G
    Davis, B
    Rowe, T
    Law, B
    CANCER RESEARCH, 2006, 66 (02) : 1070 - 1080
  • [50] The mechanism of inhibition of the cyclin-dependent kinase-2 as revealed by the molecular dynamics study on the complex CDK2 with the peptide substrate HHASPRK
    Bártová, I
    Otyepka, M
    Kríz, Z
    Koca, J
    PROTEIN SCIENCE, 2005, 14 (02) : 445 - 451